Covalent Polymer-Drug Conjugates

doi:10.3390/10010114

This article is

freely available
re-usable

Molecules 2005, 10(1), 114-125; doi:10.3390/10010114

Review

Covalent Polymer-Drug Conjugates

C. Elvira ¹^,* , A. Gallardo ¹, J. Roman ¹ and A. Cifuentes ²

¹ Institute of Polymer Science and Technology (CSIC), Spain ² Institute of Industrial Fermentations (CSIC), Spain

* Author to whom correspondence should be addressed.

Received: 13 April 2004 / Accepted: 23 June 2004 / Published: 31 January 2005

(This article belongs to the Special Issue Macromolecules Applied to Pharmaceutical Chemistry)

Download PDF Full-Text [253 KB, uploaded 20 June 2008 16:49 CET]

Abstract: In this work, polymer-drugs conjugates used as drug delivery systems (DDS) are revised attending to their chemical conjugation. Namely, the classification of this type of DDS is based on the conjugation sites of the reactive groups (i.e., via end groups or pendant polymer groups). Advantages and limitations of these types of DDS are discussed through representative examples of polymer-drugs and polymer-proteins conjugates recently developed.

Keywords: drug delivery system; DDS; polymer-drug; polymer-protein; conjugates

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Elvira, C.; Gallardo, A.; Roman, J.; Cifuentes, A. Covalent Polymer-Drug Conjugates. Molecules 2005, 10, 114-125.

AMA Style

Elvira C., Gallardo A., Roman J., Cifuentes A. Covalent Polymer-Drug Conjugates. Molecules. 2005; 10(1):114-125.

Chicago/Turabian Style

Elvira, C.; Gallardo, A.; Roman, J.; Cifuentes, A. 2005. "Covalent Polymer-Drug Conjugates." Molecules 10, no. 1: 114-125.

Molecules EISSN 1420-3049 Published by MDPI Publishing, Basel, Switzerland RSS E-Mail Table of Contents Alert